Frank Collins

Title: Innovator Spotlight: Frank Collins and His Contribution to Neurotrophic Protein Research

Introduction: Frank Collins is an innovative inventor based in Boulder, Colorado, who has made significant strides in the field of neurobiology. With a focus on neurotrophic proteins, Collins has developed an invention that advances our understanding of nerve growth factors and their applications in medicinal science.

Latest Patents: Collins holds a patent for the "Production of biologically active, recombinant members of the NGF/BDNF". This invention outlines the processes for producing mature human members of the neurotrophic proteins NGF/BDNF, which are fully biologically active. The patent also discloses the gene encoding human BDNF and processes for obtaining it. Notably, Collins identified a previously unreported member of the NGF/BDNF family, NGF-3, and described a portion of its gene. Additionally, the patent details processes for discovering other unreported members of this important protein family.

Career Highlights: Collins has made his mark at Synergen, Inc., a company known for its groundbreaking work in biotechnology. His contributions have not only furthered the company’s mission but also added valuable knowledge to the scientific community regarding neurotrophic factors' roles in neural health and potential therapeutic applications.

Collaborations: Throughout his career, Collins has collaborated with notable colleagues, including Susan Bektesh and Tadahiko Kohno. These partnerships have fostered a productive environment for innovation and research, showcasing the importance of teamwork in scientific advancement.

Conclusion: Frank Collins stands out as a prominent inventor in the field of neurobiology, with his work on neurotrophic proteins contributing to significant advancements in the understanding of nerve growth mechanisms. His dedication to research and development at Synergen, Inc. exemplifies the impactful role of inventors in pushing the boundaries of science and technology.